+499.5%
GH vs SBAC
-19.8%
+519.3%
-45.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -6.5% | +5.9% | +0.3% |
| 7D | -7.8% | -8.2% | +0.4% | -6.8% |
| 30D | -9.7% | -6.1% | -3.6% | -9.0% |
| 3M | -11.4% | -2.8% | -8.5% | -11.2% |
| 6M | +50.9% | -10.8% | +61.8% | +53.2% |
| YTD | +40.3% | -7.4% | +47.6% | +39.8% |
| 1Y | +48.5% | -8.5% | +57.0% | +48.4% |
| All | +499.5% | -19.8% | +519.3% | +557.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling